Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy (semaglutide) and Zepbound (tirzepatide) will not exceed $200. Wegovy has a ...

To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients’ ...

The multi-year deal makes Evernorth Health Services the presenting partner of NBA Total Health, a holistic health platform for fans. Official release NEW YORK – Evernorth Health Services and ...

Cigna's pharmacy benefits company, Evernorth, reached pricing deals with Eli Lilly and Novo Nordisk to reduce expenses and provide wider employer access to GLP-1 weight-loss treatments Wegovy and ...

Evernorth Health Services sees expanding opportunities in the $400 billion specialty pharmacy market, said Matt Perlberg, president of pharmacy and care delivery for the Cigna subsidiary.

In June, Evernorth made an interchangeable Humira biosimilar available, and more than 25% of eligible Accredo patients are now using the biosimilar. About Evernorth Health Services Evernorth ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Significantly, Cigna subsidiary Evernorth Health Services — which includes Express Scripts, its market-leading PBM — provided 77.9% of the company's adjusted income from operations in the ...

Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients’ copays for pricey GLP-1 weight loss medications, the health services business announced ...